Mark Finn

Cibus Genetics LLC is a biotechnology company. It develops products in agriculture and specialty chemicals. The company was founded by Peter Beetham in 2001 and is headquartered in San Diego, CA.

Cibus Ltd. is a biotechnology company, which engages in the research and development of plant gene editing technology. It focuses on the commercialization of proprietary gene-editing technology, which refer to as the Rapid Trait Development System (RTDS). The RTDS enables to introduce customizable, specific, and predictable value-enhancing traits into plants and microorganisms. The company was founded in 2001 and is headquartered in San Diego, CA.

Vantage Consulting Group, Inc. (Vantage) is an independent, SEC-registered investment advisor headquartered in Virginia Beach, Virginia. Founded in 1985, Vantage provides advisory services to individuals, high net-worth individuals, pension and profit-sharing plans, other pooled investment vehicles, charitable organizations, trust and estates, corporations, state or municipal government entities, private investment funds, investment companies, and ETFs.

Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA.

New Ventures I LLC seeks investment opportunities in companies across the globe. The fund targets companies operating in the fields of life sciences, healthcare and agriculture. It provides financing for early stage capital requirements.

New Ventures III LLC seeks investment opportunities in companies located in the United States. The fund target companies operating in the fields of therapeutics, digital medicine opportunities, and pharmaceutical royalties. It provides financing for early stage capital requirements.

Part of Scientia Ventures LLC, New Ventures II LLC is a venture capital fund.